- Previous Close
10.81 - Open
10.76 - Bid --
- Ask --
- Day's Range
10.24 - 10.80 - 52 Week Range
10.03 - 18.80 - Volume
4,189,420 - Avg. Volume
4,599,479 - Market Cap (intraday)
5.168B - Beta (5Y Monthly) 1.44
- PE Ratio (TTM)
15.31 - EPS (TTM)
0.68 - Earnings Date May 6, 2025 - May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
15.09
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio, Credelio Cat, Credelio Plus, Interceptor Plus, Doncit, Drontal, Drontal Plus, and Trifexis trademarks; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. The company also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, it offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, the company offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and TruCan trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. It sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
www.elanco.com9,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: ELAN
View More
Performance Overview: ELAN
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ELAN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ELAN
View MoreValuation Measures
Market Cap
5.17B
Enterprise Value
9.02B
Trailing P/E
15.31
Forward P/E
12.36
PEG Ratio (5yr expected)
5.15
Price/Sales (ttm)
1.17
Price/Book (mrq)
0.85
Enterprise Value/Revenue
2.03
Enterprise Value/EBITDA
6.51
Financial Highlights
Profitability and Income Statement
Profit Margin
7.61%
Return on Assets (ttm)
1.19%
Return on Equity (ttm)
5.49%
Revenue (ttm)
4.44B
Net Income Avi to Common (ttm)
338M
Diluted EPS (ttm)
0.68
Balance Sheet and Cash Flow
Total Cash (mrq)
468M
Total Debt/Equity (mrq)
72.90%
Levered Free Cash Flow (ttm)
946.75M
Research Analysis: ELAN
View MoreResearch Reports: ELAN
View MoreHOLD on weak near-term outlook
Elanco Animal Health, based in Greenfield, Indiana, provides products for both companion and food animals. It became the second-largest animal health company in the world following its acquisition of Bayer's animal health business. Founded in 1954 as part of Eli Lilly, it was spun off from Lilly through an IPO on September 24, 2018. Elanco sells its products in more than 90 countries and has a market capitalization of approximately $5.3 billion. The company has approximately 9,000 full-time employees.
RatingPrice TargetTwo big forces are hitting the markets this morning. First, Commerce Secretary
Two big forces are hitting the markets this morning. First, Commerce Secretary Howard Lutnick has indicated that there could be some tariff relief as early as today for Canada and Mexico. Second, the ADP private payrolls report showed softness in hiring last month. Investors will be looking for the February Jobs report on Friday for more detail on the state of the labor market. The yield on the 10-year Treasury note is at 4.23%. Oil is down 3% at $66 per barrel. Bitcoin is up 7% near $89,000.
Elanco Earnings: Few Surprises in Fourth Quarter and Margin Pressure Expected in 2025
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
RatingPrice TargetElanco Looks Forward to Commercialization of Key Products in 2025
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
RatingPrice Target